Biosciences Area

  • About Biosciences
    • Leadership
    • Area Operations Centers
    • Strategic Plan and Reports
    • Strategic Programs Development Group
    • Contact Information
  • Our Science
    • Area Programs
    • Strategic Initiatives
    • Biological Systems and Engineering
    • Environmental Genomics and Systems Biology
    • Molecular Biophysics and Integrated Bioimaging
    • DOE Joint Genome Institute
  • Media and Events
    • News
    • Announcements
    • Behind the Breakthroughs
    • Events Calendar
    • Seminar Series
  • Staff Resources
    • Commonly Used Acronyms
    • Communications
    • Hiring and Recruitment
    • Hybrid & Telework Resources
    • IDEA
    • Intellectual Property, Industry Engagement, and Entrepreneurship
    • LDRD Information
    • Logos and Templates
    • Mentoring Program
  • Search

Doudna Awarded 2020 Nobel Prize in Chemistry

October 7, 2020

Jennifer DoudnaBiochemist Jennifer Doudna, a professor at UC Berkeley and faculty scientist in the Molecular Biophysics and Integrated Bioimaging Division, has been awarded the 2020 Nobel Prize in Chemistry for “the development of a method for genome editing.” She shares the Nobel Prize with co-discoverer Emmanuelle Charpentier, who currently serves as the scientific and managing director of the Max Planck Unit for the Science of Pathogens in Berlin. Together, they form the first all-woman research team to be recognized with a Nobel Prize.

Doudna’s CRISPR work builds on her long history of studying various aspects of RNA, which includes some Laboratory Directed Research and Development (LDRD)-funded work on CRISPR RNA strands and the Cas1 protein. In 2012, Doudna and Charpentier’s research team detailed the underlying mechanisms of the CRISPR-Cas9 system – a component of the bacterial immune system that defends against invading viruses – and explained how it can be programmed to cut DNA at a target sequence.

Today, Doudna and Charpentier’s Nobel Prize-winning CRISPR-Cas9 technology is the basis of many promising medical technologies, including tools to diagnose and treat infections, and has many applications for the development of improved crops, biofuels, and bioproducts.

Read more in the Berkeley Lab and UC Berkeley press releases.

Was this page useful?

Send
like not like

About Biosciences

  • Leadership
  • Area Operations Centers
  • Inclusion, Diversity, Equity, and Accountability (IDEA)
  • Contact

Divisions & User Facility

  • Biological Systems and Engineering
  • Environmental Genomics and Systems Biology
  • Molecular Biophysics and Integrated Bioimaging
  • DOE Joint Genome Institute

Resources

  • A-Z Index
  • Phonebook
  • Logos
  • Acronyms
  • Integrated Safety Management
Questions & Comments
Follow us: Mastodon LinkedIn YouTube